The primary cilium, a solitary, antenna-like projection found on nearly every mammalian cell, has emerged as a crucial sensory organelle responsible for detecting extracellular mechanical and chemical signals. In the context of bone biology, the functionality of primary cilia has remained enigmatic, particularly in preosteoclasts, the precursor cells to osteoclasts responsible for bone resorption. This new study presents compelling evidence that exercise triggers mechanosensitive responses in these cells via their primary cilia, promoting a local microenvironment conducive to periosteal bone accretion.

Delving deeper into the molecular cascade, the researchers demonstrated that mechanical loading from exercise stimulates the elongation and activation of primary cilia on preosteoclasts. This morphological transformation enhances the cells’ ability to sense biomechanical cues, triggering intracellular signaling pathways that modulate gene expression relevant to bone remodeling. Notably, the activation of these cilia leads to the secretion of osteogenic factors that directly facilitate periosteal bone formation, suggesting an autocrine and paracrine communication network within the bone niche.

This study employed advanced imaging techniques, including high-resolution confocal microscopy and live-cell imaging, to visualize primary cilium dynamics in response to mechanical stimuli. The dynamically elongated cilia serve as mechanotransducers, converting biomechanical inputs into biochemical signals that engage downstream effectors, including calcium influx channels and Hedgehog signaling pathways. Such mechanotransduction underscores the intimate relationship between physical activity and bone homeostasis, providing a refined understanding of how mechanical forces optimize skeletal strength and integrity.

The researchers further conducted loss-of-function experiments by genetically ablating or impairing primary cilium formation specifically in preosteoclasts, revealing a significant attenuation of exercise-induced periosteal bone growth. These findings unequivocally establish primary cilia as indispensable mediators in the mechanical regulation of bone formation, specifically within the periosteal compartment, which is critical for cortical bone thickening and overall skeletal robustness.

Moreover, the study investigated the downstream effectors of cilia-mediated signaling, identifying key molecular players, such as the polycystin complex and specific transcription factors that modulate osteogenic gene expression. Exercise-induced activation of these pathways in preosteoclasts appears to foster a favorable balance between bone resorption and formation, tilting the scale towards anabolic processes that reinforce the periosteum — the outer fibrous layer essential for bone strength and repair.

This novel insight into preosteoclast function challenges previous dogma that primarily linked osteoblasts and osteocytes as the main responders to mechanical stimuli in bone remodeling. The role of preosteoclasts, traditionally seen as precursors to bone-resorbing osteoclasts, is now redefined as active regulators of periosteal bone formation through ciliary mechanosensing. Such a paradigm shift opens new avenues for targeting preosteoclast cilia to potentiate skeletal resilience, especially in aged or osteoporotic populations where bone fragility is a major concern.

Importantly, the researchers correlated their cellular and molecular findings with in vivo models of exercise, confirming that mechanical loading through controlled physical activity robustly enhances periosteal bone accrual dependent on intact primary cilia function. These in vivo validations accentuate the translational potential of manipulating cilia-mediated mechanotransduction pathways as a therapeutic strategy to mimic the beneficial effects of exercise in bone tissue.

In terms of clinical applications, the elucidation of exercise-stimulated primary cilia function on preosteoclasts heralds promising implications for developing targeted pharmacological agents that can activate or sensitize these mechanosensors. Such agents could potentially serve as adjunctive therapies for patients unable to perform adequate physical activity due to injury, illness, or aging, thereby preserving or enhancing bone mass and reducing fracture risk.

The intersection of mechanobiology and skeletal physiology, as highlighted by this study, reflects a broader trend in biomedical research emphasizing the importance of physical forces in cellular function and tissue regeneration. Understanding how diverse bone cell populations transcend their classical roles to integrate mechanical cues enriches our knowledge of skeletal biology and may revolutionize treatment paradigms for musculoskeletal disorders.

Given the complexity of bone remodeling, which requires the coordinated interplay among osteoblasts, osteoclasts, osteocytes, and now preosteoclasts, the identification of primary cilia on preosteoclasts as mechanosensors adds a critical piece to the puzzle. This refined understanding emphasizes the necessity for a holistic approach when designing interventions aimed at improving bone health, considering the intricate cellular crosstalk influenced by mechanical stimuli.

The temporal dynamics of cilia activation and periosteal bone formation revealed by this research also suggest that the timing and intensity of exercise regimens could be optimized to maximize bone anabolic responses. Personalized exercise prescriptions based on mechanotransduction insights might emerge as a future avenue for maximizing skeletal benefits while minimizing injury risk.

Furthermore, this discovery invites an exploration of primary cilia function beyond bone tissue, potentially uncovering similar mechanosensory roles in other mechanically active tissues such as cartilage, muscle, and vascular endothelium. The expanding relevance of cilia-mediated signaling mechanisms underscores a fundamental biological principle linking physical forces to tissue homeostasis across organ systems.

As the field moves forward, integrating multi-omics approaches, mechanobiology, and in vivo imaging will be crucial to unravel the intricate signaling networks governed by primary cilia on various cell types. The therapeutic exploitation of these pathways holds immense promise, particularly in aging populations where maintaining bone strength is imperative for mobility and quality of life.

In conclusion, the revelation that exercise-stimulated primary cilia on preosteoclasts promote periosteal bone formation is a scientific milestone that redefines our understanding of skeletal mechanobiology. This seminal work by Kim JM, Lee YS, Kim MJ, and colleagues not only advances bone biology but also opens innovative prospects for combating bone degenerative diseases through biomechanically informed therapeutic interventions. The marriage of cellular mechanosensing with exercise physiology marks a new frontier in biomedical research, poised to generate impactful health solutions for an aging global population.

Subject of Research: Mechanical regulation of periosteal bone formation through primary cilia on preosteoclasts induced by exercise.

Article Title: Exercise-stimulated primary cilia on preosteoclasts promote periosteal-bone formation.

Article References:
Kim, JM., Lee, YS., Kim, M.J. et al. Exercise-stimulated primary cilia on preosteoclasts promote periosteal-bone formation. Exp Mol Med (2026). https://doi.org/10.1038/s12276-026-01765-5

Image Credits: AI Generated

DOI: 10.1038/s12276-026-01765-5

Keywords: Primary cilia, preosteoclasts, mechanotransduction, periosteal bone formation, exercise, bone remodeling, skeletal mechanobiology, osteogenic signaling, polycystin complex, Hedgehog pathway, bone health, osteoporosis

Osteoporosis, characterized by the progressive weakening of bone density and increased fracture risk, remains a formidable public health issue worldwide. The molecular mechanisms governing osteoblast function—cells responsible for bone formation—are under intense investigation, given their potential therapeutic targets. The now-retracted article originally proposed a novel regulatory pathway involving PAX8-AS1, a long non-coding RNA, and its interaction with miR-1252-5p, influencing the expression of GNB1, a gene implicated in signal transduction pathways. This axis was suggested to orchestrate the balance between osteoblast proliferation and autophagy, a cellular degradation process essential for maintaining homeostasis and survival under stress.

Autophagy’s role within osteoblasts is particularly critical; it regulates cellular quality control by degrading damaged organelles and proteins, thus preserving cell function and viability. Dysregulation of autophagy has been implicated in various bone degenerative conditions, including osteoporosis. The initial findings indicated that knockdown of PAX8-AS1 might lead to enhanced osteoblast growth by suppressing autophagy via modulation of the miR-1252-5p/GNB1 pathway. This hypothesis positioned PAX8-AS1 as a potential molecular switch for therapeutic intervention—either by promoting bone growth or mitigating excessive autophagic activity that could contribute to bone loss.

However, scientific research is inherently iterative, and retractions, while unfortunate, play a vital role in self-correction and ensuring data integrity. The retraction notice issued by Huang, Li, Yang, and colleagues highlights the rigorous peer review and post-publication scrutiny processes that safeguard the scientific record. It also reflects the underlying challenges in deciphering complex gene regulatory networks and biochemical pathways which sometimes yield ambiguous or irreproducible results upon further analysis or replication attempts.

The retraction does not diminish the importance of investigating the interplay between non-coding RNAs and microRNAs in osteoblasts, nor the relevance of autophagy in bone biology. Instead, it serves as a crucial reminder that molecular signaling in chronic diseases like osteoporosis requires meticulously validated models and robust experimental frameworks. Future research must adopt even more stringent methodologies—including advanced genomic editing, multi-omics integration, and high-resolution imaging—to clarify the precise molecular underpinnings that govern osteoblast function and bone homeostasis.

The scientific community continues to explore the complex regulatory networks influencing bone remodeling, a process balanced delicately by osteoblasts and osteoclasts. Non-coding RNAs such as PAX8-AS1 have emerged as important modulators of gene expression, influencing cellular pathways beyond the classical protein-coding gene paradigm. MicroRNAs like miR-1252-5p are equally crucial, acting post-transcriptionally to fine-tune the expression of target genes such as GNB1. GNB1 itself functions in G-protein coupled receptor signaling, which affects numerous cellular processes including cell growth, survival, and differentiation. Unraveling these layers of regulation remains both a formidable challenge and a promising opportunity for osteoporosis treatment innovation.

The dynamic between autophagy and osteoblast proliferation is particularly intricate; autophagy is involved not only in cellular cleanup but also in energy metabolism and response to extracellular signals. Fine-tuning autophagy could provide strategies to protect osteoblasts from stress-induced apoptosis or senescence while optimizing their bone-forming capacity. Molecular targets like PAX8-AS1 and its associated signaling pathways could, in theory, modulate these processes. Nonetheless, robust experimental validation and reproducibility are paramount before clinical translations are considered.

This retraction, while disappointing for researchers who had invested considerable effort and anticipation in these findings, ultimately strengthens the integrity of molecular osteoporosis research. Scientific progress thrives on transparency and the willingness to correct course when data fall short of expected reliability. It also encourages a culture of replication studies and collaborative validation efforts across laboratories and disciplines.

As researchers refine their understanding of how non-coding RNAs and microRNAs influence cell fate decisions in bone tissue, the field moves closer to identifying viable molecular targets for pharmacological modulation. Emerging technologies like CRISPR-Cas9 genome editing, single-cell RNA sequencing, and real-time cellular imaging are accelerating discoveries in cellular biology and molecular signaling. These advancements bolster confidence that future studies will overcome existing uncertainties, leading to clearer mechanistic insights and, eventually, novel osteoporosis therapies.

Meanwhile, clinicians and patients alike await breakthroughs that transform the management of osteoporosis from symptomatic treatment to targeted molecular intervention. The pursuit of therapeutics that can precisely regulate osteoblast activity and bone remodeling pathways holds promise not only for osteoporosis but also for a spectrum of bone-related disorders. Scientific rigor and reproducibility will be essential to ensure these emerging therapies are both safe and effective.

The retraction of this article highlights the remarkable complexity inherent in delineating molecular pathways in osteoblast biology and bone disease. It illustrates how cutting-edge molecular biology intersects with clinical aspirations, and why the path from discovery to therapy is often nonlinear and fraught with challenges. Yet, it also reaffirms the resilience and self-correcting nature of scientific inquiry—a process that, despite setbacks, steadily advances human understanding and health.

As the field moves forward, attention to molecular details, thorough validation of experimental data, and interdisciplinary collaboration will be crucial. Researchers must continue to dissect the multilayered crosstalk between RNA molecules and protein signaling networks, especially within the niche environment of bone tissue. Understanding the contextual and dynamic nature of these interactions may ultimately unlock transformative strategies to combat osteoporosis and improve patient outcomes worldwide.

The retraction serves as both a cautionary tale and a motivational beacon for scientists striving to illuminate the molecular architecture of bone health. It encourages rigorous approaches and fosters ongoing dialogue within the research community, emphasizing transparency and methodological excellence. The quest to decode the molecular intricacies of osteoblast regulation remains a high priority with profound implications for public health, making the continued exploration of non-coding RNAs, microRNAs, and their downstream signaling pathways an exciting frontier in biomedical science.

Subject of Research: The role of PAX8-AS1 in osteoblast regulation and autophagy in osteoporosis.

Article Title: Retraction Note: PAX8-AS1 knockdown facilitates cell growth and inactivates autophagy in osteoblasts via the miR-1252-5p/GNB1 axis in osteoporosis.

Article References: Huang, C., Li, R., Yang, C. et al. Retraction Note: PAX8-AS1 knockdown facilitates cell growth and inactivates autophagy in osteoblasts via the miR-1252-5p/GNB1 axis in osteoporosis. Exp Mol Med (2026). https://doi.org/10.1038/s12276-026-01700-8

Image Credits: AI Generated